NIH Weekly Funding Opportunities and Policy Notices
Notice NOT-DK-22-011 from the NIH Guide for Grants and Contracts
Notice NOT-DK-22-010 from the NIH Guide for Grants and Contracts
Notice NOT-AR-21-029 from the NIH Guide for Grants and Contracts
Funding Opportunity RFA-MD-22-007 from the NIH Guide for Grants and Contracts. The purpose of this initiative is support research to develop and test community-level interventions to improve minority health and reduce health disparities.
Notice NOT-OH-22-002 from the NIH Guide for Grants and Contracts
Notice NOT-MH-22-120 from the NIH Guide for Grants and Contracts
Funding Opportunity PAR-22-075 from the NIH Guide for Grants and Contracts. The purpose of the NIAID Career Transition Award (CTA) program is to assist postdoctoral fellows' transition to positions of assistant professor or equivalent and initiate a successful biomedical career as an independent research scientist. This Funding Opportunity Announcement (FOA) is designed specifically for applicants proposing research that does not involve leading an independent clinical trial, a clinical trial feasibility study, or an ancillary clinical trial. Applicants to this FOA are permitted to propose research experience in a clinical trial led by another investigator.
Funding Opportunity RFA-TR-22-013 from the NIH Guide for Grants and Contracts. NCATS is issuing this FOA in response to the declared public health emergency issued by the Secretary, HHS. Please see Determination that a Public Health Emergency Exists Nationwide as the Result of the Opioid Crisis as renewed in Renewal of the Determination that a Public Health Emergency Exists Nationwide as the Result of the Continued Consequences of the Opioid Crisis. The Helping End Addiction Long-Term (HEAL) New Innovator Award supports a postdoctoral or newly independent Early Stage Investigator of exceptional creativity who proposes novel, original and insightful research concepts with the potential to produce a major impact, test scientific paradigms, or advance key concepts on broad, important problems in biomedical research related to pain, opioid use disorder (OUD), and/or overdose (OD). Applications proposing unexpected convergence of disciplines, new scientific directions, or the use of novel methodologies are encouraged.
Funding Opportunity RFA-HG-22-004 from the NIH Guide for Grants and Contracts. The NIH Research Education Program (R25) supports research education activities in the mission areas of the NIH. The overarching goal of this NHGRI R25 program is to support educational activities that encourage undergraduates from diverse backgrounds, including those from groups underrepresented in the biomedical workforce, to pursue further training and careers in the scientific, medical, ethical, social and/or legal areas of genomics research. To accomplish the stated over-arching goal, this FOA will support creative educational activities with a primary focus on: Research Experiences Courses for Skills Development This Genome Research Experiences to Attract Talented Undergraduates into the Genomic Field to Promote Diversity (GREAT) Program will support collaborative institutional partnerships that provide research education programs for undergraduates enrolled at minority-serving institutions (MSIs) or Institutional Development Award (IDeA)-eligible institutions. A partnership will include a MSI or IDeA-eligible institution, and one or more research-intensive institutions or organizations with a suitable research base for graduate-level training in scientific areas of interest to NHGRI.
Notice NOT-DA-22-002 from the NIH Guide for Grants and Contracts
Notice NOT-AG-22-010 from the NIH Guide for Grants and Contracts
Notice NOT-OD-22-059 from the NIH Guide for Grants and Contracts
HEAL Initiative: Advancing Health Equity in Pain and Comorbidities (R61/R33 Clinical Trial Required)
Funding Opportunity RFA-NS-22-037 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement is to solicit applications to develop, test, and implement, novel, multi-level, culturally appropriate interventions and/or adapt, test and evaluate efficacy and effectiveness of existing interventions in NIH designated populations that disproportionately experience negative health outcomes (HDP). Desired outcomes of these interventions include reduction of pain and pain-related symptoms and improvement in patient satisfaction, and overall health outcomes, including function and quality of life. Interventions that target HDPs with chronic pain in addition to at least one comorbid condition (OUD, mental health disorders and/or chronic health conditions) are of the highest priority.
Funding Opportunity RFA-HL-23-006 from the NIH Guide for Grants and Contracts. The purpose of this program is to recruit and retain outstanding, postdoctoral-level health professionals who have demonstrated potential and interest in pursuing careers as clinician-investigators. To address the growing need for this critical component of the research workforce, this funding opportunity seeks applications from institutional programs that can provide outstanding mentored research opportunities for Resident-Investigators and foster their ability to transition to individual career development research awards. The program will support institutions to provide support for up to 2 years of research conducted by Resident-Investigators in structured programs for clinician-investigators with defined program milestones. This Funding Opportunity Announcement (FOA) is designed specifically for applicants proposing research that does not involve leading an independent clinical trial, a clinical trial feasibility study, or an ancillary study to a clinical trial. Applicants to this FOA are permitted to propose research experience in a clinical trial led by a mentor or co-mentor.
Notice NOT-GM-22-029 from the NIH Guide for Grants and Contracts
Notice NOT-MH-22-100 from the NIH Guide for Grants and Contracts
Funding Opportunity RFA-TR-22-012 from the NIH Guide for Grants and Contracts. NCATS is issuing this FOA in response to the declared public health emergency issued by the Secretary, HHS. Please see Determination that a Public Health Emergency Exists Nationwide as the Result of the Opioid Crisis as renewed in Renewal of the Determination that a Public Health Emergency Exists Nationwide as the Result of the Continued Consequences of the Opioid Crisis. The purpose of this Funding Opportunity Announcement (FOA) is to solicit applications to continue support of Resource Center activities funded under RFA-TR-15-002 and RFA-TR-15-004; thus only applicants funded by RFA-TR-15-002 and RFA-TR-15-004 are eligible to apply for this FOA. Applications to this FOA will support Resource Centers (RCs) for clinical trials funded through the HEAL Pain Management Effectiveness Research Network (ERN) initiatives, including those funded under RFA-NS-19-021 and RFA-NS-20-028. Applicants are expected to continue provision of the existing HEAL ERN infrastructure to support comparative effectiveness clinical trials/studies with a shared common theme of improving pain management and reducing the reliance on opioid medications when appropriate. The RCs will provide clinical and data coordination, biostatistical resources, and recruitment and retention support. They will also continue working with other HEAL Data Coordination Resource Centers (DCRCs) to harmonize data elements creating valuable combined data sets that can be used for future meta-analyses or to add to our knowledge of under-studied pain conditions.
Funding Opportunity RFA-AI-22-003 from the NIH Guide for Grants and Contracts. This purpose of this RFA is to solicit applications for the Nonhuman Primate Transplantation Tolerance Cooperative Study Group (NHPCSG), a multi-center, cooperative program dedicated to developing, optimizing, and evaluating approaches to induce and maintain immune tolerance to allogeneic transplants in nonhuman primate (NHP) models. The over-arching goal is to facilitate clinical translation of safe and effective tolerance-induction protocols for long-term graft survival.
Notice NOT-EB-22-002 from the NIH Guide for Grants and Contracts
Notice NOT-GM-22-010 from the NIH Guide for Grants and Contracts